RB 90740: a fused pyrazine mono-N-oxide; structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
| ID Source | ID |
|---|---|
| PubMed CID | 150563 |
| SCHEMBL ID | 13041725 |
| MeSH ID | M0231526 |
| Synonym |
|---|
| rb 90740 |
| 108307-65-9 |
| imidazo(1,2-a)pyrido(3,2-e)pyrazine, 8,9-dihydro-2-(4-methyl-1-piperazinyl)-6-phenyl-, 5-oxide |
| SCHEMBL13041725 |
| rb-90740 |
| DTXSID40148495 |
| imidazo[1,2-a]pyrido[3,2-e]pyrazine, 8,9-dihydro-2-(4-methyl-1-piperazinyl)-6-phenyl-, 5-oxide |
| 12-(4-methylpiperazin-1-yl)-8-oxido-7-phenyl-2,5,13-triaza-8-azoniatricyclo[7.4.0.02,6]trideca-1(9),5,7,10,12-pentaene |
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 8 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.25) All Compounds (24.57) |
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 8 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||